We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+6%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$2.57B
AUM Growth
-$156M
Cap. Flow
-$108M
Cap. Flow %
-4.2%
Top 10 Hldgs %
15.55%
Holding
1,822
New
682
Increased
195
Reduced
247
Closed
625

Top Buys

Rank Stock Value
1
CP icon
Canadian Pacific Kansas City
CP
+$49.4M
2
DHR icon
Danaher
DHR
+$45.2M
3
WFC icon
Wells Fargo
WFC
+$44.1M
4
GLOB icon
Globant
GLOB
+$40.5M
5
EPAM icon
EPAM Systems
EPAM
+$38.7M

Sector Composition

Rank Sector Weight
1 Technology 22.06%
2 Financials 18.73%
3 Healthcare 11.64%
4 Industrials 8.6%
5 Consumer Discretionary 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEX
1701
DELISTED
NexTier Oilfield Solutions Inc.
NEX
-13,100
Closed -$60K
PRDS
1702
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
-18,718
Closed -$186K
PTRA
1703
DELISTED
Proterra Inc. Common Stock
PTRA
-374,532
Closed -$3.79M
DICE
1704
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
-40,800
Closed -$1.34M
SPPI
1705
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-63,300
Closed -$138K
LSI
1706
DELISTED
Life Storage, Inc.
LSI
-4,202
Closed -$482K
AZRE
1707
DELISTED
Azure Power Global Limited
AZRE
-11,500
Closed -$253K
BBLN
1708
DELISTED
Babylon Holdings Limited
BBLN
-1,305
Closed -$333K
RXDX
1709
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-8,791
Closed -$208K
DBD
1710
DELISTED
Diebold Nixdorf Incorporated
DBD
-14,805
Closed -$150K
TCRR
1711
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-13,100
Closed -$111K
APTX
1712
DELISTED
Aptinyx Inc. Common Stock
APTX
-44,578
Closed -$104K
ML
1713
DELISTED
MoneyLion Inc.
ML
-333
Closed -$68K
AMYT
1714
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
-11,901
Closed -$144K
AGRX
1715
DELISTED
Agile Therapeutics
AGRX
-106
Closed -$203K
SJR
1716
DELISTED
Shaw Communications Inc.
SJR
-45,767
Closed -$1.33M
ASPU
1717
DELISTED
ASPEN GROUP, INC.
ASPU
-99,827
Closed -$556K
ALR
1718
DELISTED
AlerisLife Inc
ALR
-67,595
Closed -$296K
CNCE
1719
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-126,838
Closed -$415K
LHDX
1720
DELISTED
Lucira Health, Inc. Common Stock
LHDX
-15,331
Closed -$117K
RFP
1721
DELISTED
Resolute Forest Products Inc.
RFP
-31,600
Closed -$376K
ATNX
1722
DELISTED
Athenex, Inc. Common Stock
ATNX
-2,750
Closed -$166K
PFDRU
1723
DELISTED
Pathfinder Acquisition Corporation Unit
PFDRU
-34,800
Closed -$349K
HYRE
1724
DELISTED
HyreCar Inc. Common Stock
HYRE
-28,400
Closed -$241K
PFHD
1725
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
-27,964
Closed -$526K

Similar funds

Ergoteles's Q4 2021 Portfolio in Review

As of Q4 2021, Ergoteles held 1,822 positions worth $2.57B, down 5.7% from $2.73B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ergoteles withdrew a net $108M in Q4 2021, closing 625 positions and reducing 247 holdings. Its most notable exit was Match Group, an estimated $48.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ergoteles opened a new position in Canadian Pacific Kansas City worth $48.6M.

  • Ergoteles's largest Q4 2021 buy was Canadian Pacific Kansas City: 676,212 shares worth $48.6M.
  • Ergoteles added most to Applovin in Q4 2021, an estimated $30.5M increase.
  • Ergoteles's biggest Q4 2021 reduction was Oracle, cutting an estimated $50.3M.
  • Ergoteles fully exited Match Group in Q4 2021, selling an estimated $48.3M.
  • Ergoteles's ten largest holdings make up 16% of its $2.57B portfolio in Q4 2021.
  • Ergoteles opened 682 new positions and closed 625 in Q4 2021.
  • Ergoteles's portfolio value fell 5.7% quarter-over-quarter to $2.57B.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.